Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.

Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.

PURPOSE:To estimate the influence of prolonged radiation treatment time (RTT) on survival outcomes in nasopharyngeal carcinoma after continuous intensity-modulated radiation therapy. METHODS AND MATERIALS:Retrospectively review 321 patients with NPC treated between October 2009 and December 2010 and...

Full description

Bibliographic Details
Main Authors:	Pei-Jing Li, Ting Jin, Dong-Hua Luo, Ting Shen, Dong-Mei Mai, Wei-Han Hu, Hao-Yuan Mo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4624640?pdf=render

Similar Items

The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma
by: Yi-Jun Hua, et al.
Published: (2021-09-01)

Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients
by: Xiao-Yun Li, et al.
Published: (2020-03-01)

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
by: Fangfang Kong, et al.
Published: (2018-11-01)

Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.
by: Guan-Qun Zhou, et al.
Published: (2013-01-01)

Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma.
by: Hai-yan Chen, et al.
Published: (2013-01-01)

Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
by: Songthong Anussara, et al.
Published: (2015-06-01)

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
by: Cai-neng Cao, et al.
Published: (2015-01-01)

Weekly Volumetric and Dosimetric Changes during Radiation Therapy with Intensity Modulated Radiotherapy and RapidArc Radiotherapy for Nasopharyngeal carcinomas
by: Chun I Lin, et al.
Published: (2010)

Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
by: Guanzhu Shen, et al.
Published: (2021-08-01)

Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
by: Lin Quan Tang, et al.
Published: (2015-01-01)

Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.
by: Zhong-Guo Liang, et al.
Published: (2016-01-01)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
by: Shixiu Wu, et al.
Published: (2015-01-01)

Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy
by: Qing-Hua Du, et al.
Published: (2021-04-01)

Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
by: Omer Aftab, et al.
Published: (2020-03-01)

Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma
by: Yangkun Luo, et al.
Published: (2016-01-01)

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
by: Shao-Bo Liang, et al.
Published: (2017-07-01)

The combination of systemic therapy and locoregional radiotherapy prolongs survival in newly diagnosed metastatic nasopharyngeal carcinoma patients
by: Yin Z, et al.
Published: (2017-11-01)

Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma.
by: Xuemei Ji, et al.
Published: (2013-01-01)

Nasopharyngeal Carcinoma Treated with Precision-Oriented Radiation Therapy Techniques Including Intensity-Modulated Radiotherapy: Preliminary Results
by: Wen-Shan Liu, et al.
Published: (2004-02-01)

The Value of Cervical Node Features in Predicting Long-Term Survival of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
by: Tian YM, et al.
Published: (2021-06-01)

Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
by: Jun-Fang Liao, et al.
Published: (2016-01-01)

Clinical Dosimetric Comparison among Different Intensity-Modulated Radiotherapy Plans for Nasopharyngeal Carcinoma
by: Changjiang Sun, et al.
Published: (2014-03-01)

Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma.
by: Guang Han, et al.
Published: (2014-01-01)

Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy
by: Tai-Lin Huang, et al.
Published: (2020-04-01)

Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.
by: Ji-Jin Yao, et al.
Published: (2015-01-01)

Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: A pilot study
by: Wang Jianhua, et al.
Published: (2012-01-01)

Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?
by: Shan-Shan Guo, et al.
Published: (2015-01-01)

Progression-Free Survival Prediction in Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy: Machine Learning vs. Traditional Statistics
by: Ronald Wihal Oei, et al.
Published: (2021-08-01)

Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia
by: Maklad AM, et al.
Published: (2016-10-01)

Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
by: Weidong Wang, et al.
Published: (2014-01-01)

A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy
by: Penggang Bai, et al.
Published: (2020-08-01)

A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis
by: Cheng-Yun Yao, et al.
Published: (2018-10-01)

Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma.
by: Chang-Juan Tao, et al.
Published: (2014-01-01)

Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma.
by: Mian Xi, et al.
Published: (2013-01-01)

Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
by: Li Q, et al.
Published: (2021-08-01)

The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy
by: Shun Tasaka, et al.
Published: (2021-05-01)

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma
by: Dehuan Xie, et al.
Published: (2019-04-01)

Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma
by: Ning Han, et al.
Published: (2019-08-01)

A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
by: Liang Peng, et al.
Published: (2020-09-01)

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
by: Zhai RP, et al.
Published: (2015-11-01)